Related Experiment Videos
Prognostic indicators in invasive breast cancer
1Division of Oncology University of Texas Health Science Center, San Antonio.
The Surgical Clinics of North America
|October 1, 1990
Summary
Tumor size and lymph node status are key breast cancer prognostic factors. Estrogen/progesterone receptors, DNA ploidy, and proliferation rates offer additional insights into patient survival and treatment response.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Tumor size and axillary lymph node status are primary determinants of breast cancer clinical course.
- Estrogen and progesterone receptor status are crucial prognostic factors for survival and hormonal therapy response.
- Histologic grading, while valuable, has limitations due to poor reproducibility.
Purpose of the Study:
- To evaluate the prognostic value of various factors in breast cancer.
- To explore the utility of flow cytometry for DNA content and proliferative rate analysis.
- To assess the combined prognostic significance of ploidy and S-phase fraction.
Main Methods:
- Analysis of tumor size, lymph node involvement, estrogen/progesterone receptor status, and histologic grade.
- Flow cytometry to determine DNA ploidy and S-phase fraction.
- Evaluation of oncogene amplification (HER-2/neu) and overexpression.
Main Results:
- Aneuploid tumors and high S-phase fractions correlate with shorter survival and increased relapse risk.
- A combined index of diploidy and low S-phase identifies low-risk node-negative patients.
- HER-2/neu amplification/overexpression may indicate prognosis in node-positive patients.
Conclusions:
- Tumor size, lymph node status, hormone receptor status, DNA ploidy, proliferation rate, and HER-2/neu status are important prognostic indicators in breast cancer.
- Flow cytometry provides valuable prognostic information, particularly when combining ploidy and S-phase data.
- These factors aid in risk stratification and guiding treatment decisions for breast cancer patients.